What Is Our COVID-19 Future? Building the New Normal

Ezekiel J. Emanuel, MD, PhD, is the Vice Provost for Global Initiatives and Diane v.S. Levy and Robert M. Levy University Professor at the University of Pennsylvania. He is also Co-Director of the Health Transformation Institute.  Dr. Emanuel is a Special Advisor to the Director General of the World Health Organization, Senior Fellow at the Center for American Progress, and member of the Council on Foreign Relations. From January 2009 to January 2011, he served as special advisor for health policy to the director of the Office of Management and Budget in the White House. From 1997 to 2011, he was chair of the Department of Bioethics at the National Institutes of Health. Dr. Emanuel has written and edited 15 books and over 300 scientific articles. He is a regular guest on CNN and MSNBC, and often publishes pieces in the New York Times, The Atlantic, and the Washington Post.

Céline Gounder, MD, ScM, FIDSA, Senior Fellow and Editor-at-Large for Public Health at the Kaiser Family Foundation, is the creator and host of American Diagnosis, a podcast on health and social justice, and Epidemic, a podcast about infectious diseases, now produced by KHN. An internist, infectious disease specialist, and epidemiologist, she volunteers on the wards at NYC Health + Hospitals’ Bellevue Hospital, which is affiliated with NYU Grossman School of Medicine. She has been a frequent guest on CBS, CNN, MSNBC, and NBC. She was an Assistant Commissioner of Health in New York City. Between 1998 and 2012, she studied tuberculosis and HIV in South Africa, Lesotho, Malawi, Ethiopia, and Brazil. Dr. Gounder also served on the Biden-Harris Transition COVID-19 Advisory Board.

Luciana Borio, MD, is a Venture Partner at ARCH Venture Partners. In this capacity, she advises on and helps develop new investment opportunities related to biologics manufacturing, clinical trials, novel therapies, and areas with large unmet clinical needs. Dr. Borio is a specialist in biodefense, emerging infectious diseases, medical product development, and complex public health emergencies. Prior to joining ARCH, she was a Senior Vice President at In-Q-Tel, an independent, non-profit, strategic investment firm that works to deliver innovative technology solutions to support the missions of the U.S. Intelligence Community. Past positions include serving as a member of President Biden’s transition COVID-19 Advisory Board and Director for Medical and Biodefense Preparedness at the National Security Council (2017-2019), where she coordinated the response to the Ebola epidemic in West Africa, efforts to combat antimicrobial resistance, and the development of an Executive Order to modernize America's influenza vaccines. Prior to that, she was the Acting Chief Scientist of the U.S. Food and Drug Administration (2015-2017) and the Assistant Commissioner for Counterterrorism Policy of the FDA (2010-2017). Dr. Borio is an adjunct Assistant Professor of Medicine at Johns Hopkins University (2003-present) and a Senior Fellow for Global Health at the Council on Foreign Relations.